Fortis Healthcare Limited
FORTIS
Κατάταξη σε μετοχές
#3027
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare... Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
Τιμή μετοχής
$8.00
Κεφαλαιοποίηση
$6.04B
Αλλαγή (1 ημέρα)
-1.73%
Αλλαγή (1 έτος)
-35.85%
Χώρα
IN
Εμπόριο Fortis Healthcare Limited (FORTIS)
Κατηγορία
Healthcare
Δείκτης P/B για Fortis Healthcare Limited (FORTIS)
Δείκτης P/B στις October 2026 TTM: 5.61
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Fortis Healthcare Limited, ο τρέχων δείκτης P/B (TTM) είναι 5.61. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 4.23.
Ιστορικό P/B για την Fortis Healthcare Limited από 2002 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 5.61 | -3.76% |
| 2025 | 5.83 | 37.90% |
| 2024 | 4.23 | 55.98% |
| 2023 | 2.71 | -23.65% |
| 2022 | 3.55 | 44.44% |
| 2021 | 2.46 | 71.83% |
| 2020 | 1.43 | 7.28% |
| 2019 | 1.33 | -34.41% |
| 2018 | 2.03 | -10.20% |
| 2017 | 2.26 | -6.57% |
| 2016 | 2.42 | 7.77% |
| 2015 | 2.25 | 76.86% |
| 2014 | 1.27 | -12.70% |
| 2013 | 1.46 | -26.61% |
| 2012 | 1.98 | -31.40% |
| 2011 | 2.89 | -49.39% |
| 2010 | 5.71 | 73.01% |
| 2009 | 3.30 | -14.32% |
| 2008 | 3.85 | -65.22% |
| 2007 | 11.08 | -46.53% |
| 2006 | 20.72 | -92.72% |
| 2005 | 284.65 | -3.64% |
| 2004 | 295.40 | 31.31% |
| 2003 | 224.97 | 57.91% |
| 2002 | 142.46 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| -15.9433 | -384.14% |
US
|
|
| - | - |
DE
|
|
| 4.8701 | -13.20% |
US
|
|
| 9.3882 | 67.32% |
SA
|
|
| 4.6058 | -17.91% |
BR
|
